![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Veranova, L.p. West Deptford Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Veranova: A CDMO that manages complexity with confidence.
One of their significant offerings is Cisplatin, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2005-253 - Rev 01
This Chemical Type CEP, issued on November 29, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 599 associated with this CEP further emphasizes